Quantcast
Last updated on April 17, 2014 at 10:14 EDT

Latest balloon catheter Stories

2012-05-14 02:27:40

MAHWAH, N.J., May 14, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new MEGA 7.5Fr. 30cc and 40cc intra-aortic balloon (IAB) catheters. These new, larger volume catheters will allow clinicians to provide patients with greater hemodynamic support, regardless of their height. "The MEGA family of catheters represents a true...

2012-05-01 02:29:57

LAGUNA HILLS, Calif., May 1, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced today that it has received Conformite Europeenne (CE) Mark approval for its V2 Renal Denervation System(TM) for the treatment of hypertension. Renal denervation is a percutaneous, catheter-based therapy that uses RF energy to disrupt renal sympathetic nerves whose hyperactivity leads to...

2012-04-24 02:30:03

NATICK, Mass., April 24, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces CE Mark and European market launch of the Emerge(TM) PTCA[1] Dilatation Catheter. The Emerge Catheter is a next-generation pre-dilatation balloon catheter designed specifically to offer exceptional deliverability to address challenging lesions. The company plans to launch the product immediately in CE Mark countries in both Monorail® and Over-The-Wire (OTW) options. Commercial availability...

2012-04-12 02:37:48

LAGUNA HILLS, Calif., April 12, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced today that veteran medical device sales and marketing executive Michael D. Gioffredi has been named Chief Commercialization Officer. Gioffredi has worked as an executive in the medical device industry for over 25 years and for the past six years served as Senior Vice President of Sales and...

2012-02-23 10:00:00

LAGUNA HILLS, Calif., Feb. 23, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today initial patient treatments in the international multi-center REDUCE-HTN renal denervation clinical study for uncontrolled hypertension. REDUCE-HTN is a non-randomized, prospective, single cohort, 64-patient clinical study designed to validate the clinical performance of the Vessix V2 Renal Denervation System(TM) for...

2012-02-13 05:00:00

LAGUNA HILLS, Calif., Feb. 13, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that it will make its first detailed public presentation of preclinical data relating to its new V2 Renal Denervation System(TM) on Saturday, February 18, 2012 at the TRenD Workshop 2012, in Frankfurt, Germany. The presentation, titled "Percutaneous RF balloon-mediated renal denervation in under a minute: The V2...

2012-01-18 14:36:00

LAGUNA HILLS, Calif., Jan. 18, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that the first public presentation of its new percutaneous V2 Renal Denervation System(TM) for the treatment of medication-resistant hypertension will be made at LINC 2012 in Leipzig, Germany on Thursday, January 26, 2012. Renal denervation is a new percutaneous catheter-based technique for the treatment...

2011-11-16 05:00:00

NEW YORK, Nov. 16, 2011 /PRNewswire/ -- Hotspur Technologies today announced the launch of the company's GPSCath(TM) Balloon Dilatation Catheter in the United States and select international markets. The company made the announcement today. Hotspur's innovative GPSCath(TM) Balloon Dilatation Catheter integrates a proprietary valve into a balloon catheter, allowing physicians to inject contrast during a procedure without the need for removal of the balloon catheter or...

2011-11-15 05:00:00

NEW YORK, Nov. 15, 2011 /PRNewswire/ -- Dr. Lisa Liberatore, prominent Otolaryngologist (Ear, Nose and Throat Surgeon) located in the Upper East Side of New York City, provides a helpful and informative link to a YouTube video of her patient undergoing an In-Office Balloon Sinuplasty procedure that provides extraordinary relief to patients suffering with chronic sinus problems. Normally something that is done under general anesthesia and in a hospital setting, Dr. Liberatore is one of the...

2011-11-10 15:36:00

WARRENDALE, Pa., Nov. 10, 2011 /PRNewswire/ -- Bayer HealthCare's affiliate MEDRAD, Inc. today announced that five-year data from the THUNDER trial* demonstrated a 59 percent relative reduction in target lesion revascularization (TLR) rates in popliteal arteries of patients with peripheral arterial disease (PAD) treated with the Cotavance® drug eluting balloon with Paccocath® technology compared to standard balloon angioplasty (POBA). Additionally, for...


Latest balloon catheter Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »